LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 4.36 | 84.90 | 667 | 322 | 2.0678 | 1.9165 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 4.36 | 84.90 | 10 | 322 | 0.0310 | -0.6706 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 4.36 | 84.90 | 374 | 322 | 1.1594 | 1.1597 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 6.06 | 84.90 | 767 | 365 | 2.0988 | 1.8439 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 6.06 | 84.90 | 17 | 365 | 0.0465 | -0.5341 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 6.06 | 84.90 | 407 | 365 | 1.1137 | 1.1049 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.77 | 84.90 | 822 | 411 | 1.9988 | 1.7113 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.77 | 84.90 | 22 | 411 | 0.0535 | -0.4475 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 7.77 | 84.90 | 715 | 411 | 1.7387 | 1.5501 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 9.47 | 84.90 | 870 | 447 | 1.9444 | 1.6392 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 9.47 | 84.90 | 38 | 447 | 0.0849 | -0.2848 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 9.47 | 84.90 | 1005 | 447 | 2.2462 | 1.8028 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 11.18 | 84.90 | 903 | 492 | 1.8340 | 1.5404 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 11.18 | 84.90 | 46 | 492 | 0.0934 | -0.2147 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 11.18 | 84.90 | 545 | 492 | 1.1069 | 1.0817 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.88 | 84.90 | 927 | 531 | 1.7458 | 1.4690 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.88 | 84.90 | 67 | 531 | 0.1262 | -0.0856 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 12.88 | 84.90 | 607 | 531 | 1.1431 | 1.1038 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 14.58 | 84.90 | 13 | 663 | 0.0196 | -0.4688 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 14.58 | 84.90 | 1001 | 663 | 1.5089 | 1.2975 | MN20160318_Q02 | D08 |